These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26330482)

  • 1. Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer.
    O'Mara TA; Glubb DM; Painter JN; Cheng T; Dennis J; ; Attia J; Holliday EG; McEvoy M; Scott RJ; Ashton K; Proietto T; Otton G; Shah M; Ahmed S; Healey CS; Gorman M; Martin L; ; Hodgson S; Fasching PA; Hein A; Beckmann MW; Ekici AB; Hall P; Czene K; Darabi H; Li J; Dürst M; Runnebaum I; Hillemanns P; Dörk T; Lambrechts D; Depreeuw J; Annibali D; Amant F; Zhao H; Goode EL; Dowdy SC; Fridley BL; Winham SJ; Salvesen HB; Njølstad TS; Trovik J; Werner HM; Tham E; Liu T; Mints M; ; Bolla MK; Michailidou K; Tyrer JP; Wang Q; Hopper JL; ; Peto J; Swerdlow AJ; Burwinkel B; Brenner H; Meindl A; Brauch H; Lindblom A; Chang-Claude J; Couch FJ; Giles GG; Kristensen VN; Cox A; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Thompson DJ; Spurdle AB
    Endocr Relat Cancer; 2015 Oct; 22(5):851-61. PubMed ID: 26330482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
    Painter JN; O'Mara TA; Batra J; Cheng T; Lose FA; Dennis J; Michailidou K; Tyrer JP; Ahmed S; Ferguson K; Healey CS; Kaufmann S; Hillman KM; Walpole C; Moya L; Pollock P; Jones A; Howarth K; Martin L; Gorman M; Hodgson S; ; ; De Polanco MM; Sans M; Carracedo A; Castellvi-Bel S; Rojas-Martinez A; Santos E; Teixeira MR; Carvajal-Carmona L; Shu XO; Long J; Zheng W; Xiang YB; ; Montgomery GW; Webb PM; Scott RJ; McEvoy M; Attia J; Holliday E; Martin NG; Nyholt DR; Henders AK; Fasching PA; Hein A; Beckmann MW; Renner SP; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Lambrechts D; Coenegrachts L; Schrauwen S; Amant F; Winterhoff B; Dowdy SC; Goode EL; Teoman A; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Ashton K; Proietto T; Otton G; Tzortzatos G; Mints M; Tham E; ; Hall P; Czene K; Liu J; Li J; Hopper JL; Southey MC; ; Ekici AB; Ruebner M; Johnson N; Peto J; Burwinkel B; Marme F; Brenner H; Dieffenbach AK; Meindl A; Brauch H; ; Lindblom A; Depreeuw J; Moisse M; Chang-Claude J; Rudolph A; Couch FJ; Olson JE; Giles GG; Bruinsma F; Cunningham JM; Fridley BL; Børresen-Dale AL; Kristensen VN; Cox A; Swerdlow AJ; Orr N; Bolla MK; Wang Q; Weber RP; Chen Z; Shah M; French JD; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Edwards SL; Thompson DJ; Spurdle AB
    Hum Mol Genet; 2015 Mar; 24(5):1478-92. PubMed ID: 25378557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
    Doherty JA; Rossing MA; Cushing-Haugen KL; Chen C; Van Den Berg DJ; Wu AH; Pike MC; Ness RB; Moysich K; Chenevix-Trench G; Beesley J; Webb PM; Chang-Claude J; Wang-Gohrke S; Goodman MT; Lurie G; Thompson PJ; Carney ME; Hogdall E; Kjaer SK; Hogdall C; Goode EL; Cunningham JM; Fridley BL; Vierkant RA; Berchuck A; Moorman PG; Schildkraut JM; Palmieri RT; Cramer DW; Terry KL; Yang HP; Garcia-Closas M; Chanock S; Lissowska J; Song H; Pharoah PD; Shah M; Perkins B; McGuire V; Whittemore AS; Di Cioccio RA; Gentry-Maharaj A; Menon U; Gayther SA; Ramus SJ; Ziogas A; Brewster W; Anton-Culver H; ; ; Pearce CL;
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):245-50. PubMed ID: 20056644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
    Li Y; Li Y; Wedrén S; Li G; Charn TH; Desai KV; Bonnard C; Czene K; Humphreys K; Darabi H; Einarsdóttir K; Heikkinen T; Aittomäki K; Blomqvist C; Chia KS; Nevanlinna H; Hall P; Liu ET; Liu J
    Breast Cancer Res; 2011 Jan; 13(1):R10. PubMed ID: 21269472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas.
    Fejerman L; Chen GK; Eng C; Huntsman S; Hu D; Williams A; Pasaniuc B; John EM; Via M; Gignoux C; Ingles S; Monroe KR; Kolonel LN; Torres-Mejía G; Pérez-Stable EJ; Burchard EG; Henderson BE; Haiman CA; Ziv E
    Hum Mol Genet; 2012 Apr; 21(8):1907-17. PubMed ID: 22228098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor alpha gene polymorphism and endometrial cancer risk--a case-control study.
    Wedrén S; Lovmar L; Humphreys K; Magnusson C; Melhus H; Syvänen AC; Kindmark A; Landegren U; Fermér ML; Stiger F; Persson I; Baron JA; Weiderpass E
    BMC Cancer; 2008 Nov; 8():322. PubMed ID: 18990228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor polymorphisms and the risk of endometrial cancer.
    Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
    BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk-associated variants at 6q25.1 influence risk of hepatocellular carcinoma in a Chinese population.
    Li J; Wang Y; Zhu Y; Gong Y; Yang Y; Tian J; Zhang Y; Zou D; Peng X; Ke J; Gong J; Zhong R; Chang J
    Carcinogenesis; 2017 Apr; 38(4):447-454. PubMed ID: 28334234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a single nucleotide polymorphism at 6q25.1,rs2046210, with endometrial cancer risk among Chinese women.
    Li G; Xiang YB; Courtney R; Cheng JR; Huang B; Long JR; Cai H; Zheng W; Shu XO; Cai Q
    Chin J Cancer; 2011 Feb; 30(2):138-43. PubMed ID: 21272446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival.
    Einarsdóttir K; Darabi H; Czene K; Li Y; Low YL; Li YQ; Bonnard C; Wedrén S; Liu ET; Hall P; Liu J; Humphreys K
    Br J Cancer; 2009 Apr; 100(8):1358-64. PubMed ID: 19319135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse associations between ESR1 polymorphism and breast cancer development and progression.
    Ding SL; Yu JC; Chen ST; Hsu GC; Hsu HM; Ho JY; Lin YH; Chang CC; Fann CS; Cheng CW; Wu PE; Shen CY
    Clin Cancer Res; 2010 Jul; 16(13):3473-84. PubMed ID: 20570923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women.
    Son BH; Kim MK; Yun YM; Kim HJ; Yu JH; Ko BS; Kim H; Ahn SH
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):633-45. PubMed ID: 25323936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.
    Barzan D; Veldwijk MR; Herskind C; Li Y; Zhang B; Sperk E; Du WD; Zhang XJ; Wenz F
    Eur J Hum Genet; 2013 Nov; 21(11):1286-92. PubMed ID: 23486537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa.
    Shahzad S; Khan NU; Sombal W; Shah RU; Khan AU; Iqbal A; Munir I
    Mol Biol Rep; 2023 Mar; 50(3):2445-2451. PubMed ID: 36595122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis.
    Li N; Dong J; Hu Z; Shen H; Dai M
    Breast Cancer Res Treat; 2010 May; 121(1):177-84. PubMed ID: 19760036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in ESR1 and FLJ43663 are associated with breast cancer risk in the Han population.
    Xia P; Jin T; Geng T; Sun T; Li X; Dang C; Kang L; Chen C; Sun J
    Tumour Biol; 2014 Mar; 35(3):2187-90. PubMed ID: 24127041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESR1 and EGF genetic variation in relation to breast cancer risk and survival.
    Einarsdóttir K; Darabi H; Li Y; Low YL; Li YQ; Bonnard C; Sjölander A; Czene K; Wedrén S; Liu ET; Hall P; Humphreys K; Liu J
    Breast Cancer Res; 2008; 10(1):R15. PubMed ID: 18271972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
    PLoS One; 2016; 11(4):e0153314. PubMed ID: 27070141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study.
    Healey CS; Ahmed S; ; ; O'Mara TA; Ferguson K; ; Lambrechts D; Garcia-Dios DA; Vergote I; Amant F; ; Howarth K; Gorman M; Hodgson S; Tomlinson I; ; Yang HP; Lissowska J; Brinton LA; Chanock S; Garcia-Closas M; ; Hall P; Liu J; ; Shah M; Pharoah PD; Thompson DJ; ; Rebbeck TR; Strom BL; Dunning AM; Easton DF; Spurdle AB
    Carcinogenesis; 2011 Dec; 32(12):1862-6. PubMed ID: 21965274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between ESR1 PvuII, XbaI, and P325P Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis.
    Zhang Y; Zhang M; Yuan X; Zhang Z; Zhang P; Chao H; Jiang L; Jiang J
    Med Sci Monit; 2015 Oct; 21():2986-96. PubMed ID: 26434778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.